MedTrace Logo

Artificial Intelligence Neuropathologist

NCT05300113 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2022-03-29

No results posted yet for this study

Summary

CNS tumor requires biopsy for pathological diagnosis, which is known as the "golden standard". We would like to achieve automated classification of brain tumors based on deep learning in digital histopathology images and molecular pathology results. We expect to develop an assistant system (including software and hardware), to help pathologists during their diagnosis for CNS tumor.

Conditions

  • CNS Tumor
  • Neuropathology

Sponsors & Collaborators

  • United Imaging Healthcare

    collaborator UNKNOWN

  • Huashan Hospital

    lead OTHER

Principal Investigators

  • Jinsong Wu, Ph.D. & M.D · Huashan Hospital

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-01
Primary Completion
2023-12-01
Completion
2024-12-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05300113 on ClinicalTrials.gov